Skip to main content
Premium Trial:

Request an Annual Quote

FDA Renews License to GVK Bio’s Biomarker Database

Premium

GVK Biosciences said this week that the US Food and Drug Administration has renewed its license to the Hyderabad, India-based firm's clinical biomarker database.

GVK Bio said that the FDA’s biomarker qualification group renewed its license to the GVK BIO Online Biomarker Database, or GOBIOM, database.

GOBIOM contains clinically evaluated, exploratory, and preclinical biomarkers associated with different therapeutic areas that have been reported in global clinical trials, clinical, and preclinical studies.

Specifically, the resource contains data related to about 20,000 biochemical, genomic, imaging, metabolite, cellular, and physiological biomarkers as well as experimental, analytical, clinical, and statistical information.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.